Published in Diabetes on March 01, 1985
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A (1990) 2.18
Histopathology of diabetic nephropathy. Semin Nephrol (2007) 1.60
Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest (1988) 1.39
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg (1989) 1.19
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol (2008) 1.02
Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis (2014) 1.01
Quality of life of pancreas transplant recipients. Diabetologia (1991) 0.95
Muscle capillary basement membrane width in patients with vacor-induced diabetes mellitus. J Clin Invest (1986) 0.88
Pancreas transplantation. Gut Liver (2010) 0.81
Pancreas transplantation--registry report and a commentary. West J Med (1985) 0.77
The pathogenesis and prevention of diabetic nephropathy. West J Med (1986) 0.76
Coming of age for pancreas transplantation. West J Med (1989) 0.75
Pancreatic Islet Cell Transplantation: A new era in transplantation. Can Fam Physician (1992) 0.75
Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. Transplantation (1993) 0.75
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 2.91
Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72
Kidney donors live longer. Transplantation (1997) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia (2002) 2.35
Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
An everting technique for intraluminal vascular suturing. Surg Gynecol Obstet (1968) 2.12
HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08
Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90
Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia (2006) 1.87
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73
Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72
Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med (1968) 1.68
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63
Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden. J Intern Med (2004) 1.61
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60
Effects on tissue fine structure of variations in colloid osmotic pressure of glutaraldehyde fixatives. J Ultrastruct Res (1970) 1.57
No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up. Transplantation (2001) 1.57
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab (2000) 1.48
Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes (1983) 1.48
Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy. Clin Nephrol (1992) 1.41
Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings--evidence from annual registry data in 1990-2005. Diabetologia (2009) 1.41
Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes. Scand J Clin Lab Invest (2005) 1.39
Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39
Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation (1988) 1.38
Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet (1987) 1.38
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.35
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
Regional differences in the control of lipolysis in human adipose tissue. Metabolism (1979) 1.35
Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet (1983) 1.33
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
Subcellular localization of the prostaglandin system in the rabbit renal papilla. Acta Physiol Scand (1972) 1.32
Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet (1984) 1.31
Increased mortality in diabetes during the first 10 years of the disease. A population-based study (DISS) in Swedish adults 15-34 years old at diagnosis. J Intern Med (2001) 1.31
Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats. Nephrol Dial Transplant (2000) 1.30
Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia (2012) 1.27
Studies of cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis (1982) 1.27
Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet (1983) 1.26
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. Scand J Rheumatol (2005) 1.22
Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant (2006) 1.21
Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21
Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus. Diabetes (1982) 1.20
Hypertriglyceridemia in renal transplant recipients treated with sirolimus. Transplant Proc (1998) 1.19
Perspectives in organ transplantation. Antibiot Chemother (1969) 1.19
Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18
Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1987) 1.18
Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation (1999) 1.16
Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes (1989) 1.14